Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 5:00 PM
Study NCT ID:
NCT05245760
Status:
WITHDRAWN
Last Update Posted:
2022-11-08
First Post:
2022-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer
Sponsor:
Zhonglin Hao
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-08
First Submit QC Date:
None
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL